Health Skyhawk Therapeutics Secures $2 Billion Boost from Merck KGaA Skyhawk Therapeutics has received a significant financial boost in its mission to advance RNA-targeted therapies, securing an additional $2 billion from Merck KGaA. This... Editorial19 hours ago